NASDAQ:IMCC IM Cannabis (IMCC) Stock Price, News & Analysis → Your Money is Not Safe (From American Alternative) (Ad) Free IMCC Stock Alerts $0.53 +0.12 (+28.89%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$0.43▼$0.5450-Day Range$0.20▼$0.5352-Week Range$0.19▼$1.43Volume638,692 shsAverage Volume650,285 shsMarket Capitalization$7.10 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Get IM Cannabis alerts: Email Address IM Cannabis MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy0.49% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.41Based on 7 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.48) to ($0.18) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.88 out of 5 stars N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for IM Cannabis. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.49% of the float of IM Cannabis has been sold short.Short Interest Ratio / Days to CoverIM Cannabis has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in IM Cannabis has recently decreased by 61.09%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldIM Cannabis does not currently pay a dividend.Dividend GrowthIM Cannabis does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for IMCC. Previous Next 2.5 News and Social Media Coverage News SentimentIM Cannabis has a news sentiment score of 0.41. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 7 news articles for IM Cannabis this week, compared to 0 articles on an average week.Search InterestOnly 1 people have searched for IMCC on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows1 people have added IM Cannabis to their MarketBeat watchlist in the last 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, IM Cannabis insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 5.91% of the stock of IM Cannabis is held by insiders.Percentage Held by InstitutionsOnly 7.68% of the stock of IM Cannabis is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for IM Cannabis are expected to grow in the coming year, from ($0.48) to ($0.18) per share.Price to Book Value per Share RatioIM Cannabis has a P/B Ratio of 0.22. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad American AlternativeYour Money is Not SafeBiden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…CLICK HERE TO GET YOUR GUIDE NOW About IM Cannabis Stock (NASDAQ:IMCC)IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands. The company serves medical patients. IM Cannabis Corp. is headquartered in Tel Aviv, Israel.Read More IMCC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IMCC Stock News HeadlinesMarch 28, 2024 | msn.comRockford man charged with selling crack cocaine, cannabisMarch 28, 2024 | prnewswire.comIM Cannabis Reports 2023 Financial ResultsMarch 29, 2024 | American Alternative (Ad)Your Money is Not SafeBiden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…March 26, 2024 | americanbankingnews.comIM Cannabis (IMCC) Scheduled to Post Earnings on ThursdayMarch 25, 2024 | prnewswire.comIMC Expects Accelerated Growth in Germany from the Country's Groundbreaking Cannabis LegalizationMarch 20, 2024 | prnewswire.comIM Cannabis to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 28 at 9:00am ETMarch 18, 2024 | msn.comBusinesses ready to go on Kentucky medical marijuana. Why can't they proceed?February 28, 2024 | finanznachrichten.deIM Cannabis Corp.: IMC Announces Potential Reverse Merger with Kadimastem a leading Clinical cell therapy companyMarch 29, 2024 | American Alternative (Ad)Your Money is Not SafeBiden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…February 28, 2024 | finance.yahoo.comKadimastem Takes Another Step Towards Signing the Merger Agreement with Nasdaq Listed IMCCFebruary 28, 2024 | finance.yahoo.comIMC Announces Potential Reverse Merger with Kadimastem a leading Clinical cell therapy companyFebruary 15, 2024 | thestreet.comIM Cannabis Corp. NewsJanuary 12, 2024 | finanznachrichten.deIM Cannabis Corp.: IMC Reschedules the Final Payment of the Oranim Pharmacy AcquisitionJanuary 12, 2024 | finance.yahoo.comIMC Reschedules the Final Payment of the Oranim Pharmacy AcquisitionJanuary 2, 2024 | finanznachrichten.deIM Cannabis Corp.: IMC Announces the Conclusion of the Planning and Construction Legal ProceedingsJanuary 2, 2024 | finance.yahoo.comIMC Announces the Conclusion of the Planning and Construction Legal ProceedingsDecember 8, 2023 | finance.yahoo.comNew Israeli cannabis regulation, facilitating access for many new patients, scheduled for December 29, 2023, has been postponed by three months; Israeli Ministry of Health published a new report showing a surge in new medical cannabis patients in November 2023November 8, 2023 | finance.yahoo.comIM Cannabis to Report Third Quarter 2023 Financial Results on Monday, November 13 at 9:00am ETOctober 10, 2023 | finanznachrichten.deIM Cannabis Corp.: IM Cannabis Announces the appointment of Uri Birenberg as Chief Financial OfficerOctober 10, 2023 | finance.yahoo.comIM Cannabis Announces the appointment of Uri Birenberg as Chief Financial OfficerOctober 6, 2023 | cbsnews.comMichigan man growing cannabis worth millions won't face major charges, court saysSeptember 25, 2023 | msn.com"We got this wrong:" Minnesota's first legal cannabis director quits after one daySeptember 12, 2023 | msn.comMum defends decision to smoke medical marijuana while pregnantAugust 8, 2023 | finance.yahoo.comIM Cannabis to Report Second Quarter 2023 Financial Results on Monday, August 14 at 9:00am ETAugust 7, 2023 | benzinga.comInternational Medical Marijuana Operator Gets NASDAQ Warning As Stock Price Drops Below $1August 1, 2023 | msn.comOwner of "I'm Stuck" cannabis stores speaks out on allegations amidst closuresJuly 12, 2023 | benzinga.com'Bipartisan Lawmakers Push For Marijuana And Psychedelics Amendments To Defense Bill, But Committee Action Is Delayed' - Marijuana MomentSee More Headlines Receive IMCC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IM Cannabis and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today3/29/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medicinals & botanicals Sub-IndustryN/A Current SymbolNASDAQ:IMCC CUSIPN/A CIK1792030 Webwww.imcannabis.com Phone972-54-433-1111FaxN/AEmployees283Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-145,290,000.00 Net MarginsN/A Pretax Margin13.20% Return on Equity21.99% Return on Assets8.74% Debt Debt-to-Equity Ratio0.02 Current Ratio1.01 Quick Ratio0.62 Sales & Book Value Annual Sales$41.79 million Price / Sales0.17 Cash FlowN/A Price / Cash FlowN/A Book Value$2.42 per share Price / Book0.22Miscellaneous Outstanding Shares13,390,000Free Float12,599,000Market Cap$7.10 million OptionableNot Optionable Beta0.85 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. Marc Lustig M.B.A. (Age 50)M.Sc., Executive Chairman Comp: $208.51kMr. Oren ShusterCEO & DirectorMr. Richard BallaCEO & Director of German Operations Adjupharm GmbHMr. Michael Ruscetta (Age 55)Chief Executive Officer of Trichome Financial Corp. Comp: $94.85kMr. Howard Steinberg C.F.A. (Age 59)Chief Executive Officer of TJAC & MYM Comp: $520.16kMs. Rinat Efrima (Age 47)Chief Executive Officer of IMC Holdings Ltd. Mr. Uri Birenberg (Age 48)Chief Financial Officer Advocate Michal Lebovitz NissimovGeneral CounselMore ExecutivesKey CompetitorsMannatechNASDAQ:MTEXKinetaNASDAQ:KAYumanity TherapeuticsNASDAQ:YMTXNexImmuneNASDAQ:NEXIPulmatrixNASDAQ:PULMView All Competitors IMCC Stock Analysis - Frequently Asked Questions Should I buy or sell IM Cannabis stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for IM Cannabis in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" IMCC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in IMCC, but not buy additional shares or sell existing shares. View IMCC analyst ratings or view top-rated stocks. How have IMCC shares performed in 2024? IM Cannabis' stock was trading at $0.3570 on January 1st, 2024. Since then, IMCC shares have increased by 48.5% and is now trading at $0.53. View the best growth stocks for 2024 here. Are investors shorting IM Cannabis? IM Cannabis saw a drop in short interest in March. As of March 15th, there was short interest totaling 42,100 shares, a drop of 61.1% from the February 29th total of 108,200 shares. Based on an average trading volume of 370,400 shares, the short-interest ratio is presently 0.1 days. Approximately 0.5% of the shares of the stock are short sold. View IM Cannabis' Short Interest. When is IM Cannabis' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our IMCC earnings forecast. When did IM Cannabis' stock split? IM Cannabis's stock reverse split on Wednesday, November 16th 2022. The 1-10 reverse split was announced on Wednesday, November 16th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, November 16th 2022. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. Who are IM Cannabis' major shareholders? IM Cannabis' stock is owned by a number of institutional and retail investors. Top institutional investors include Concourse Financial Group Securities Inc. (0.00%). How do I buy shares of IM Cannabis? Shares of IMCC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:IMCC) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeYour Money is Not SafeAmerican AlternativeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaThe ONE AI Sock to own now. (It’s not Nvidia.)Weiss Ratings“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IM Cannabis Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.